Fintel on MSN

ABIVAX Société Anonyme - Depositary Receipt (ABVX) Price Target Increased by 12.94% to 122.45

The average one-year price target for ABIVAX Société Anonyme - Depositary Receipt (NasdaqGM:ABVX) has been revised to $122.45 ...
TipRanks on MSN

Abivax announces patient-reported outcomes from ABTECT trial

Abivax (ABVX) announced patient-reported outcomes from its Phase 3 ABTECT 8-week induction trials evaluating obefazimod in adult patients with ...
Fintel on MSN

Nanobiotix S.A. - Depositary Receipt (NBTX) Price Target Increased by 48.88% to 21.89

The average one-year price target for Nanobiotix S.A. - Depositary Receipt (NasdaqGS:NBTX) has been revised to $21.89 / share. This is an increase of 48.88% from the prior estimate of $14.71 dated ...